🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › California › San Diego

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an San Diego, CA

Tha 13 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air San Diego (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • University of San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

A’ fastadhSgrùdadh amharc
  • University of California San Diego, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

A’ fastadhÌre 3
  • Scripps Cancer Center ( Site 0052), La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06393374

Intratumoral N17350 in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07339176

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

A’ fastadhÌre 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06400472

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07029399

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • University of California, San Diego; Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

A’ fastadhÌre 2
  • University of California San Diego, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT01042379

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

A’ fastadhÌre 1
  • UCSD Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06908928

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A’ fastadhÌre 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2025 · NCT06682793

A Beta-only IL-2 ImmunoTherapY Study

A’ fastadhÌre 1/2
  • Sharp Memorial Hospital, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2025 · NCT05086692

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

A’ fastadhÌre 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Gearr 2024 · NCT04282044

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an San Diego

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.